| Literature DB >> 26552985 |
Ronald S Veazey1, Udayan Chatterji2, Michael Bobardt2, Kasi E Russell-Lodrigue1, Jian Li3, Xiaolei Wang1, Philippe A Gallay4.
Abstract
A safe and effective vaginal microbicide could decrease human immunodeficiency virus (HIV) transmission in women. Here, we evaluated the safety and microbicidal efficacy of a short amphipathic peptide, C5A, in a rhesus macaque model. We found that a vaginal application of C5A protects 89% of the macaques from a simian-human immunodeficiency virus (SHIV-162P3) challenge. We observed no signs of lesions or inflammation in animals vaginally treated with repeated C5A applications. With its noncellular cytotoxic activity and rare mechanism of action, C5A represents an attractive microbicidal candidate.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26552985 PMCID: PMC4704173 DOI: 10.1128/AAC.01925-15
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191